Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 292.4 Million SAR | 70.68% |
| 2022 | 171.31 Million SAR | 0.36% |
| 2021 | 170.69 Million SAR | -17.48% |
| 2020 | 206.86 Million SAR | 31.82% |
| 2019 | 156.93 Million SAR | 4.04% |
| 2018 | 150.83 Million SAR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 94.99 Million SAR | -11.19% |
| 2024 Q1 | 102.96 Million SAR | 131.47% |
| 2024 Q2 | 106.95 Million SAR | 3.87% |
| 2023 Q4 | 44.48 Million SAR | -42.41% |
| 2023 FY | 292.4 Million SAR | 70.68% |
| 2023 Q3 | 77.24 Million SAR | -10.46% |
| 2023 Q2 | 86.26 Million SAR | 2.21% |
| 2023 Q1 | 84.39 Million SAR | 165.77% |
| 2022 Q2 | 50.42 Million SAR | 15.83% |
| 2022 Q1 | 43.53 Million SAR | -26.54% |
| 2022 FY | 171.31 Million SAR | 0.36% |
| 2022 Q4 | 31.75 Million SAR | -30.36% |
| 2022 Q3 | 45.6 Million SAR | -9.56% |
| 2021 FY | 170.69 Million SAR | -17.48% |
| 2021 Q4 | 59.26 Million SAR | 0.0% |
| 2021 Q3 | 59.26 Million SAR | 43.87% |
| 2021 Q2 | 41.19 Million SAR | 57.9% |
| 2021 Q1 | 26.08 Million SAR | 0.0% |
| 2020 FY | 206.86 Million SAR | 31.82% |
| 2019 FY | 156.93 Million SAR | 4.04% |
| 2018 FY | 150.83 Million SAR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | -13.71 Million SAR | 2232.595% |